Adherence to omalizumab: a real-life study

被引:0
|
作者
Campisi, Raffaele [1 ]
Crimi, Claudia [1 ]
Noto, Alberto [2 ]
Foschino, Maria Pia [3 ]
Valenti, Giuseppe [4 ]
Viviano, Vittorio [4 ]
Pelaia, Corrado [5 ]
Ricciardi, Luisa [6 ]
Scichilone, Nicola [7 ]
Crimi, Nunzio [8 ]
机构
[1] AOU Policlin Vittorio Emanuele, Resp Med Unit, Catania, Italy
[2] AOU Policin G Martino, Anesthesia & Intens Care Unit, Messina, Italy
[3] Univ Foggia, Inst Resp Dis, Dept Med & Surg Sci, Foggia, Italy
[4] Ctr Individuato ASMA GRAVE, Ctr Riferimento Aziendale Terr Prevenz Malattie A, Palermo, Italy
[5] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy
[6] Univ Messina, Sch & Div Allergy & Clin Immunol, Dept Human Pathol, Messina, Italy
[7] Univ Palermo, Sez Pneumol, Dipartimento Biomed Med Interna & Specialist DIBI, Palermo, Italy
[8] Univ Catania, Resp Med Unit, Dept Clin & Expt Med, AOU Policlin Vittorio Emanuele, Catania, Italy
关键词
Asthma; -; management; Quality of life; Adherence;
D O I
10.1183/13993003.congress-2019.PA2525
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
PA2525
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Italian real-life experience of omalizumab
    Cazzola, M.
    Camiciottoli, G.
    Bonavia, M.
    Gulotta, C.
    Ravazzi, A.
    Alessandrini, A.
    Caiaffa, M. F.
    Berra, A.
    Schino, P.
    Di Napoli, P. L.
    Maselli, R.
    Pelaia, G.
    Bucchioni, E.
    Paggiaro, P. L.
    Macchia, L.
    RESPIRATORY MEDICINE, 2010, 104 (10) : 1410 - 1416
  • [2] Omalizumab in chronic inducible urticaria: A retrospective, real-life study
    Fialek, M.
    Dezoteux, F.
    Le Moinga, A.
    Karimova, E.
    Ramdane, N.
    Pape, E.
    Azib-Meftah, S.
    Staumont-Salle, D.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2021, 148 (04): : 262 - 265
  • [3] Real-life treatment of cholinergic urticaria with omalizumab
    Altrichter, Sabine
    Chuamanochan, Mati
    Knoth, Henriette
    Asady, Aida
    Ohanyan, Tatevik
    Metz, Martin
    Maurer, Marcus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : 788 - +
  • [4] Response to omalizumab in patients with severe allergic asthma: A real-life study
    Zierau, Louise
    Waisted, Emil Schwarz
    Thomsen, Simon Francis
    Backer, Vibeke
    RESPIRATORY MEDICINE, 2017, 131 : 109 - 113
  • [5] Can the response to Omalizumab be influenced by treatment duration? A real-life study
    Sposato, Bruno
    Scalese, Marco
    Latorre, Manuela
    Novelli, Federica
    Scichilone, Nicola
    Milanese, Manlio
    Olivieri, Carmela
    Perrella, Antonio
    Paggiaro, Pierluigi
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2017, 44 : 38 - 45
  • [6] Safety of omalizumab in chronic urticaria during pregnancy: a real-life study
    Patruno, Cataldo
    Guarneri, Fabrizio
    Nettis, Eustachio
    Bonzano, Laura
    Filippi, Federica
    Ribero, Simone
    Foti, Caterina
    Rubegni, Pietro
    Balato, Anna
    Miniello, Andrea
    Motolese, Alfonso
    Piraccini, Bianca Maria
    Quaglino, Pietro
    Romita, Paolo
    Lazzeri, Laura
    Buononato, Dario
    Dastoli, Stefano
    Raia, Flavia
    Napolitano, Maddalena
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 49 (04) : 344 - 347
  • [7] Omalizumab is effective in nasal polyposis with or without asthma, a real-life study
    Tat, Tugba Songul
    WORLD ALLERGY ORGANIZATION JOURNAL, 2022, 15 (08):
  • [8] Omalizumab for the treatment of chronic urticaria: Real-life findings
    Hamelin, A.
    Amster, E.
    Mathelier-Fusade, P.
    Pecquet, C.
    Bayrou, O.
    Barbaud, A.
    Soria, A.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2019, 146 (01): : 9 - 18
  • [9] Omalizumab for chronic spontaneous urticaria in real-life practice
    Cubiro, Xavier
    Spertino, Jorge
    Puig, Lluis
    Serra-Baldrich, Esther
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB209 - AB209
  • [10] Real-life experiences with omalizumab for the treatment of chronic urticaria
    Sussman, Gordon
    Hebert, Jacques
    Barron, Carly
    Bian, Jia
    Caron-Guay, Rose-Marie
    Laflamme, Stephanie
    Stern, Simon
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 112 (02) : 170 - 174